Risk screening for spontaneous preterm labour
- PMID: 17462957
- DOI: 10.1016/j.bpobgyn.2007.03.004
Risk screening for spontaneous preterm labour
Abstract
Prevention of viable spontaneous preterm birth before 34 weeks' gestation through screening is one of the key aims of antenatal care as birth below this threshold of prematurity has implications for child, mother and society. If women can be identified to be at high risk of spontaneous preterm birth in early pregnancy, they can be targeted for more intensive antenatal surveillance and prophylactic interventions (primary prevention). However, the disease mechanisms behind preterm birth are not well understood. Consequently, tests for its prediction and treatments for its prevention are not well developed. Additionally, no randomised controlled trial focusing on prevention of spontaneous preterm birth related perinatal morbidity and mortality through a screening programme exists. This chapter describes a generic framework for combining screening information with therapeutic effect to delineate its role in a screening programme. We use test-treatment combination of previous history of preterm birth and progestational agents as an example. A decision-making framework is built using: (1) evidence for post-test probabilities; (2) evidence for therapeutic effectiveness; and (3) integration of the two evidences to estimate the effect of the test-treatment combination with numbers needed to treat (NNTs). The NNT to prevent one case of spontaneous preterm birth before 34 weeks' gestation with progesterone is seven in women with a previous history; NNT is 41 in women without a previous history; and it is 28 when previous history was not used to guide a decision about prevention. The proposed framework makes decisions about screening and prevention explicit.
Similar articles
-
17 hydroxyprogesterone for the prevention of preterm delivery.Obstet Gynecol. 2005 May;105(5 Pt 1):1128-35. doi: 10.1097/01.AOG.0000160432.95395.8f. Obstet Gynecol. 2005. PMID: 15863556 Review.
-
Preterm labour. Pharmacological prevention of prematurity.Best Pract Res Clin Obstet Gynaecol. 2007 Oct;21(5):843-56. doi: 10.1016/j.bpobgyn.2007.03.010. Epub 2007 May 4. Best Pract Res Clin Obstet Gynaecol. 2007. PMID: 17482517 Review.
-
Do screening-preventative interventions in asymptomatic pregnancies reduce the risk of preterm delivery--a critical appraisal of the literature.Eur J Obstet Gynecol Reprod Biol. 2006 Aug;127(2):145-59. doi: 10.1016/j.ejogrb.2006.02.001. Epub 2006 Mar 6. Eur J Obstet Gynecol Reprod Biol. 2006. PMID: 16517046 Review.
-
Fetal fibronectin as a predictor of spontaneous preterm labour in asymptomatic women with a cervical cerclage.BJOG. 2009 May;116(6):799-803. doi: 10.1111/j.1471-0528.2009.02137.x. BJOG. 2009. PMID: 19432568
-
Primary predictors of preterm labour.BJOG. 2005 Mar;112 Suppl 1:38-47. doi: 10.1111/j.1471-0528.2005.00583.x. BJOG. 2005. PMID: 15715593 Review.
Cited by
-
Use of progesterone supplement therapy for prevention of preterm birth: review of literatures.Obstet Gynecol Sci. 2017 Sep;60(5):405-420. doi: 10.5468/ogs.2017.60.5.405. Epub 2017 Sep 18. Obstet Gynecol Sci. 2017. PMID: 28989916 Free PMC article. Review.
-
Association between prenatal care utilization and risk of preterm birth among Chinese women.J Huazhong Univ Sci Technolog Med Sci. 2017 Aug;37(4):605-611. doi: 10.1007/s11596-017-1779-8. Epub 2017 Aug 8. J Huazhong Univ Sci Technolog Med Sci. 2017. PMID: 28786063
-
Inflammatory response in maternal serum during preterm labour.Facts Views Vis Obgyn. 2014;6(1):19-30. Facts Views Vis Obgyn. 2014. PMID: 25009722 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical